Aging populations and modern lifestyles are driving a degenerative diseases pandemic

As lifespans have increased globally, so too have the challenges associated with maintaining health throughout those extended years. Despite advancements, HealthSpan—the period of life spent in good health—has not kept pace, primarily due to the prevalence of degenerative diseases. 

Unbalanced lifestyles and the elongation of lifespan contribute to the exacerbation of age-related disorders and underlying health issues. This imbalance results in a greater burden on healthcare systems and diminished quality of life for individuals. 

Addressing this disparity requires a focus on slowing the aging process itself. By targeting the mechanisms of senescence—the biological aging process—we can treat degenerative diseases yet existing solutions are palliative only.

Our Mission

At the heart of our mission is the desire to tackle degenerative diseases. To achieve this, we dedicate ourselves to a healthier elder lifespan through the development of a Technology Platform to slowdown cells aging & inflammatory conditions and to cure high prevalence unmet medical needs.

Through our platform, we’ve developed a miRNA-enhanced exosome based therapeutic portfolio, leveraging to enhance exosomes intrinsic anti-inflammatory and regenerative properties, amplified with loaded cargo, particularly miRNA. 

Our Vision

Our Technology Platform & Therapeutic Pipeline